Cantel Medical Corporation
CMD
CMD was delisted on the 1st of June, 2021.
254 hedge funds and large institutions have $2.47B invested in Cantel Medical Corporation in 2019 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 100 increasing their positions, 81 reducing their positions, and 30 closing their positions.
29% more call options, than puts
Call options by funds: $2.29M | Put options by funds: $1.77M
23% more repeat investments, than reductions
Existing positions increased: 100 | Existing positions reduced: 81
13% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 30
0% more funds holding
Funds holding: 253 → 254 (+1)
6% less capital invested
Capital invested by funds: $2.62B → $2.47B (-$153M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$62.3M |
| 2 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$42.9M |
| 3 |
RP
Riverbridge Partners
Minneapolis,
Minnesota
|
+$24.6M |
| 4 |
State of New Jersey Common Pension Fund D
Trenton,
New Jersey
|
+$24.2M |
| 5 |
Select Equity Group
New York
|
+$17.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$38.8M |
| 2 |
RIM
Ranger Investment Management
Dallas,
Texas
|
-$26.1M |
| 3 |
Westfield Capital Management
Boston,
Massachusetts
|
-$15.7M |
| 4 |
DM
Diker Management
New York
|
-$14.9M |
| 5 |
BlackRock
New York
|
-$14M |
CMD Hedge Fund Activity: Q1 2019 in Review
254 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Cantel Medical Corporation (CMD) for Q1 2019, worth a combined $2.47B — down 5.8% from $2.62B a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new CMD positions and 30 closed out — a net gain of 4 holders — while 100 added to existing stakes and 81 trimmed.
The largest buyer was Champlain Investment Partners, adding an estimated $62.3M. The largest seller was Invesco, cutting an estimated $38.8M.
- 254 institutional investors held Cantel Medical Corporation (CMD) as of Q1 2019, up from 253 in Q4 2018.
- Funds reported $2.47B of Cantel Medical Corporation stock for Q1 2019, down 5.8% quarter-over-quarter.
- 34 funds opened new Cantel Medical Corporation positions in Q1 2019 and 30 closed out, a net change of +4 holders.
- The largest Cantel Medical Corporation buyer in Q1 2019 was Champlain Investment Partners, an estimated $62.3M added.
- The largest Cantel Medical Corporation seller in Q1 2019 was Invesco, an estimated $38.8M sold.
Based on aggregated 13F filings for Q1 2019.